Nicotine or marijuana vaping exposure during pregnancy and altered immune responses in offspring
0
, ... Abstract
Electronic nicotine delivery systems (ENDS) - which include electronic cigarettes or e-cigarettes, or simply e-cigs, and marijuana vaping have become increasingly popular. ENDS devices have been established as one of the tobacco quit methods and promoted to be safer compared to traditional tobacco cigarettes. Emerging evidence demonstrates that
Keywords
INTRODUCTION
Since the landmark 1964 report by the United States Surgeon General[1], tobacco smoking has been established to contain more than 70 carcinogens, which are associated with multiple cancers, primarily lung cancer[2]. Efforts for lung cancer prevention have used various tobacco cessation approaches such as nicotine patches, lozenges, and gum. However, since 2006, electronic nicotine delivery systems (ENDS) have become a popular alternative for nicotine replacement therapy. ENDS products encompass a variety of devices, including vape pens, pods, mods, and electronic cigarettes, commonly referred to as e-cigarettes.
The National Academies of Sciences, Engineering and Medicine’s committee on the review of the health effects of ENDS identified health consequences of e-cigarettes and listed a set of conclusions based on the cancer endpoint studied and the level of evidence provided. This committee then found no available evidence on whether or not e-cigarette use is associated with intermediate cancer endpoints in humans. The committee also found limited evidence from biomarker-based in vivo animal studies to support the hypothesis that long-term
Given the still building evidence on the carcinogenicity of ENDS and marijuana vaping, no study on humans has been reported on the long-term cancer outcomes on children born from mothers who smoked or were exposed to either nicotine or marijuana vaping, or both, during pregnancy. Nevertheless, for the established carcinogens known to cross the placental barrier, there is a need to assess cancer risk in the offspring, using the same conceptual framework presented by the National Academies’ review committee[19]. To this end, we aimed to summarize the level of evidence to date for altered immune responses with a special focus on cancer risks in the offspring resulting from vaping nicotine or marijuana, or both, during pregnancy. Specifically, we conducted a literature review using the PubMed database. To assist with our review, we sought to answer the following questions:
(1) What are the currently identified carcinogens contained in the nicotine and marijuana aerosols and devices, respectively?
(2) Which of these carcinogens are known to cross the placental barrier, and at what proportion compared to their respective concentrations in the mother’s biological samples?
(3) Are these carcinogens associated with (future) risk of cancer in the offspring?
METHODS
Search strategy
We searched PubMed for relevant studies published between 2003 (the year the first electronic cigarettes were marketed) and December 2022. Our initial search string combined key words related to (1) the compounds identified in ENDS; (2) ENDS; and (3) pregnancy. However, this strategy yielded no study and we needed to combine results from separate component search strings, which are well detailed in the Supplementary Materials. Noteworthy, all component strings that combined “marijuana vaping”, or associated terms, with pregnancy yielded no studies. A possible explanation is the newness of this category of vaping devices and their still low inclusion in research involving pregnant women. Therefore, to capture the available data on the offspring’s prenatal exposure to marijuana compounds, we expanded our search to studies involving marijuana and pregnancy, without the search term “vaping”. However, such exposure should afterward be restricted to the only compounds identified in marijuana vape devices[41]. We also reviewed reference lists from the relevant studies yielded by this search, as well as studies obtained from colleagues and those from individual journals that had been previously identified by the team but not captured by this search strategy.
Screening
We initially screened titles and abstracts and excluded irrelevant articles, then screened full articles for final inclusion. The full list of our full-paper inclusion and exclusion criteria is available in the Supplementary Materials. Among others, we excluded articles if: (1) they were commentaries, letters to the editor, editorials, qualitative studies, etc.; (2) they discussed ENDS- or marijuana-contained substances, but without their health consequences; (3) they were published before 2003 or after 2022. Each reviewer (JMN and SC) screened studies independently at both phases and the two reviewers resolved discrepancies together in discussions. Figure 1 shows the number of included and excluded papers.
Figure 1. PRISMA diagram showing the number of papers sorted through each stage of screening for this review article.
DISCUSSION
Herein, we conducted a narrative review on the potential for ENDS- and marijuana vaping-associated chemical exposures (either through active maternal nicotine or marijuana vape, or passive aerosols from another householder) to introduce carcinogenic compounds to and impact a developing fetus. We acknowledge that there are numerous other sources of environmental contaminants and the potential for transfer of organic contaminants (and/or their metabolites) to the developing fetus. However, this is beyond the scope of the current work, and herein, we only discuss ENDS- and marijuana vaping-associated chemical exposures.
Both nicotine and cannabis vapes contain complex mixtures of chemicals, and such complexity increases with thermal degradation chemistry[42]. The study by Li et al. underscores the need for further research on individual components to gain a thorough understanding of aerosol composition from using various vaping devices while accounting for individual user settings[43].
It is important to acknowledge that a discussion on the measurement of metabolites or adducts of carcinogenic substances would be helpful, since some of these compounds require metabolic activation to exert adverse effects. Some birth cohort studies, even with low smoking prevalence, have shown that urinary biomarker values and self-reported smoking can be used to assess passive exposures[44]. Interestingly, one birth cohort study observed an association between offspring DNA methylation and metabolites of cigarette smoke (except for nicotine)[45]. Presumably, the toxic effects of prenatal nicotine exposure may be exerted by downstream metabolites, rather than nicotine. While cotinine and NNAL could be used as a measure of tobacco smoke exposure, cotinine may be a more precise candidate to detect passive exposures[46]. Metabolic intermediates of tobacco-specific nitrosamines such as 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol (NNAL) and its glucuronides, as well as 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK), are potent carcinogens[47]. Then, during further biotransformation, metabolic intermediates of NNAL and NNK such as methane diazonium ions can react with DNA to form methyl adducts, such as 7-methylguanine
Excessive oxidative stress, such as oxidative damage to DNA, cells, and other macromolecules, has been implicated in cancer initiation and promotion[49,50]. The subject of our focus in this review, the developing fetus, has few defense capabilities of protecting itself from enhanced oxidative stress and inflammation that may come from ENDS- or marijuana vapor-associated chemicals that enter the maternal-fetal circulation. For instance, fetuses have reduced antioxidants and limited activities of most antioxidative enzymes[51] as their organs are still in the formation stages. As such, the fetus may be at increased risk for cancer initiation or promotion because of increased reactive oxygen and nitrogen signaling, oxidative DNA damage, or even alterations in its genomic structure introduced by these exogenous compounds through maternal or environmental nicotine or marijuana vape use. We postulate that prenatal programming of cancer may occur with exposures to ENDS- or vaping marijuana-associated compounds. Moreover, as has been proposed before with marijuana vape oil[52] and with ENDS[53], we hypothesize that certain types of cancer may be initiated in the developing fetus, due to the combination of low antioxidative activity and increased oxidative stress and inflammation. We provide a brief summary of the studies that informed our hypothesis [Tables 1 and 2]. For the rest of the discussion, we consider three main questions below, addressed separately regarding ENDS and marijuana vape devices.
Studies included in this narrative review for ENDS
| Question | Ref. | Species | Exposure | Relevant results |
| What are the currently identified carcinogens contained in the ENDS aerosols? | Holt et al.[54] | NA | N/A. 241 e-liquids were submitted for analysis by individuals, purchased directly from manufacturers, or purchased from local retailers | A total of 350 chemicals including nicotine, caffeine, menthol, and ethanol |
| Lim and Shin[55] | NA | NA. Authors wanted to detect VOCs in refill liquids and cartridges of e-cigs | A total of 14 VOCs were detected including benzene, toluene, ethylbenzene, m-xylene, p-xylene, and o-xylene | |
| Yan et al.[56] | NA | Aerosols from two open-system devices were characterized with Orbitrap mass spectrometer | Positive identification of over 30 compounds including nicotine and its oxide compounds, newly formed nicotine adducts with propylene glycol, ethyl maltol, tributylamine, and dibutylamine, as well as some aliphatic and aromatic oxygen-containing compounds which are yet to be determined | |
| Which ones of them are known to cross the placental barrier, and at what proportion compared to their respective concentrations in the mother’s blood? | Ballbè et al.[57] | Human | Passive exposures to daily e-cigarette use from a first-generation device from father | Glycerol and metals (Al, Cr, Ni, Cu, Zn, Sn, and Pb) were in the cord blood |
| Are these carcinogens associated with altered immune response and (future) risk of cancer in the offspring? | Cahill et al.[58] | BALB/c mice | Active cinnamon-flavored e-cig aerosols from mother | Altered lung structure and function and sex-specific molecular signatures during lung alveologenesis. Genes associated with Wnt signaling were dysregulated |
| Cahill et al.[59] | BALB/c mice | Active mint-flavored JUUL aerosols from mother | Decreased body weights and lengths after birth. There was also dysregulation of 24 genes in the lungs of the offspring related to Wnt signaling, 9 genes related to epigenetics, and 7 genes related to inflammation. At 11 weeks of age, JUUL + HDM-exposed offspring exhibited pulmonary inflammation compared to their respective air + HDM controls. Additionally, JUUL + HDM female offspring showed decreased methylation of the promoter region of the Il10ra gene | |
| Chen et al.[60] | Female BALB/c mice | E-cigarette liquid without nicotine and e-cigarette liquid containing 18 mg/mL of nicotine | TNF-a protein levels were increased in the electronic cigarette groups (compared to controls), and IL-1b was suppressed in adult offspring. Additionally, methylation increased in the e-cigarette liquid without nicotine (~3X) and e-cigarette liquid containing 18 mg/mL of nicotine (~2X) | |
| Chua et al.[61] | 33-year-old male | Had previously used cannabis and e-cigarettes | Serum had anti-granulocyte-macrophage colony-stimulating factor antibodies were present. Vitamin E (but not VE acetate) was detected in his bronchoalveolar lavage fluid | |
| Church et al.[62] | Female CD-1 mice | propylene glycol and vegetable glycerol, or to PG/VG with 16 mg/mL of nicotine | Reduction in IL-4 and IFN-gamma in the diencephalon. There were also lower levels of hippocampal IFN gamma in females only. Additionally, e-cigarette exposure without nicotine resulted in a 2-fold increase of IL-6 in the cerebellum | |
| Lee et al.[63] | FVB/N male mice and human BEAS-2B and UROtsa | 10 mg/mL of e-cig aerosols | E-cig aerosols can cause DNA damage in lungs, hearts, and bladders of mice. E-cigs exposures can also impair DNA-repair and alter the functions of lung proteins. Nicotine and its nitrosation product 4-(methylnitrosamine)-1-(3-pyridyl)-1-butanone enhanced mutations and tumorigenic cell transformation in cultured human lung and bladder cells | |
| Hickman et al.[64] | Neutrophils from the blood of healthy human subjects | “Cinnamaldehyde, ethyl vanillin, benzaldehyde, benzaldehyde PG acetal, and isoamyl acetate” | Cinnamaldehyde and ethyl vanillin exposures led to decreased oxidative burst. Benzaldehyde and benzaldehyde propylene glycol acetal impaired phagocytosis | |
| Landmesser et al.[65] | Humans | 25 healthy adult males [5 regular smokers, 10 regular vapers (vaping labeled e-liquid at 10 W), and 10 regular vapers (vaping labeled e-liquid at 18 W)] | Degradation products formaldehyde acetaldehyde and acrolein were formed from the precursors’ propylene glycol and glycerol in e-liquid during vaping | |
| Li et al.[66] | BALB/c mice | Mice were exposed to air or tobacco cigarette smoke for 6 weeks prior to mating, during gestation and lactation. Then, a subset received e-cigarettes with nicotine after mating until pups weaned. Lastly, another group was exposed to e-cigs with or without nicotine for 6 weeks prior to mating until pups weaned | In comparison to dams with continuous cigarette smoke exposures, replacement of traditional cigarette smoke with e-cig resulted in less adverse impacts on the offspring’s renal development and albuminuria. However, continuous e-cig exposure during pregnancy resulted in increased kidney markers of oxidative stress, renal inflammation, and fibrosis in the adult offspring | |
| Li et al.[67] | BALB/c mice | Mice were exposed to e-cigs with or without nicotine for 6 weeks prior to mating until pups weaned | E-cig (without nicotine) exposure during pregnancy led to metabolic changes and liver damage in offspring. On the other hand, e-cigs with nicotine led to induced hepatic steatosis but not liver damage in the adult offspring | |
| Noël et al.[68] | BALB/c mice | Mice were exposed to 36 mg/mL of nicotine cinnamon-flavored e-cig aerosols for 14-31 days [for either 12 days before mating plus during gestation (preconception groups) or only during gestation (prenatal groups)] | There was an e-cig immunosuppressive effect among the mice exposed to e-cigs during preconception and prenatal exposures. The exposed offspring had decreased birth weights and lengths, and in the preconception group, 7 inflammation-related genes were downregulated. Additionally, 75 genes involved in Wnt signaling were downregulated | |
| Orzabal et al.[69] | Sprague Dawley rats | Mice were exposed to aerosols from e-cigs with and without nicotine (e-cig base had 80:20 propylene glycol and glycerol | There were 984 genes that were downregulated and 2,322 genes that were upregulated among offspring exposed to e-cigs compared to unexposed offspring and these differentially expressed genes mapped to 159 disrupted cellular pathways | |
| Rickard et al.[70] | HepG2 Cells | Cells were exposed to isoamyl acetate, vanillin, ethyl vanillin, ethyl maltol, L-menthol, and trans-cinnamaldehyde | Vanillin, ethyl vanillin, ethyl maltol, and L-menthol exposure led to the decreased viability of HepG2 cells (>30% decrease in cell viability). On the other hand, PG/VG may not decrease viability on their own but may inflict damage when contained in a mixture with various flavoring chemicals | |
| Wang et al.[71] | CD-1 mice | E-cig aerosols (50% PG, 50% VG, and 16% nicotine) | Adult offspring of mice exposed to in-utero e-cig had an increased abundance of lymphoid enhancer-binding factor 1, fibronectin, and E-cadherin. On the other hand, altered E-cadherin and peroxisome proliferator-activated receptor γ levels were observed only in males exposed to e-cig aerosols with nicotine. Then, lipogenic and myogenic mRNAs were dysregulated in adult offspring in a sex-dependent manner. PAI-1, an extracellular matrix regulator, was significantly increased in females exposed prenatally to e-cig aerosols with nicotine and in males exposed to e-cig aerosols in comparison to control animals. Matrix metalloproteinase 9, a downstream target of PAI-1, was downregulated in both sexes exposed to e-cig aerosols with nicotine during pregnancy |
Studies included in this narrative review for marijuana vaping
| Question | Ref. | Species | Exposure | Relevant results |
| What are the currently identified carcinogens contained in marijuana vapor? | Tang et al.[31] | NA | Mixtures of different proportions of 12 vaporizable cannabis concentrates (terpenoids and high molecular weight compounds) were heated at 100-500 °C in a room-sized chamber to simulate emissions | Acrolein (1.3-3.9 μg·m-3) and methacrolein (2.0 μg·m-3), along with nine other degradation byproducts, were quantified, and a large amount of ultrafine particles were released when the mixture was heated and remained airborne for at least 3 h |
| Canchola et al.[72] | NA | Vitamin E acetate vaping emissions (temperature ranging from 176 to 356 °C) | DL-alpha tocopherol acetate, 1-Pristene, 1-Heptene, 2,6-dimethyl, DL-alpha tocopherol, Duroquinone, 1-Dodecanol, 3,7,11-trimethyl, 1-Undecene, 4-methyl, 1-Heptene, 2-methyl, Durohydroquinone, 1-Decene, 4 methyl, 2,6,10-Trimethylundeca-1,3-diene, 3,7,11,15-Tetramethyl-2-hexadecen-1-ol (Phytol), Dodecane,2,6,10-trimethyl, 1,4-Benzenediol, 2,3,5-trimethyl, 2,6-Dimethyl-1,6-heptadiene, 1-Octene,3,7-dimethyl, and 1-Octene,3-methyl found at different temperatures | |
| Guo et al.[41] | NA | N/A. Twelve cannabis vape cartridges were obtained through the California state surveillance program and major constituents in vape oil liquid, vape oil vapor, and vape oil aerosol phases were tested | Identified more than 100 terpenes and natural extracts, 19 cannabinoids, and other potential toxic additives such as Vitamin E Acetate, Polyethylene Glycols, and Medium Chain Triglycerides | |
| LeBouf et al.[73] | NA | NA. vitamin E acetate, vitamin E, coconut, and MCT oil | Alcohols, aldehydes, ketones, and saturated and unsaturated hydrocarbons were identified and were due to volatilization, thermal degradation, or reactions (oxidation or rearrangements) | |
| Li et al.[43] | NA | NA. To assess carbonyls, organic acids, cannabinoids, and terpenes in the vaping aerosol of pure VEA, purified THC oil, and an equal volume mixture of VEA and THC oil at various coil temperatures (100-300 °C) | The degradation of VEA and cannabinoids occurred via radical oxidation and direct thermal decomposition pathways. The authors observed that THC oil tended to aerosolize and degrade more compared to VEA at a given temperature. Toxic carbonyls such as formaldehyde, 4-methylpentanal, glyoxal, or diacetyl and its isomers increased in VEA e-liquid when normalized to particle mass | |
| Meehan-Atrash et al.[74] | NA | NA. To evaluate the safety of vaporizing concentrated cannabis extracts as a function of gas-phase reaction products | Users may be exposed to degradants such as isoprene (3.0 × 10-2 - 6.0 × 100 μg), methacrolein (5.6 × 10-3 - 1.9 × 10-1 μg), benzene (9.9 × 10-1 - 3.6 × 101 ng), and methyl vinyl ketone when using cartridge vaporizers at 3.2 V, 4.0 V, and 4.8 V, and higher quantities when using dabbing Additionally, the study estimated cancer and noncancer risks associated with exposure to these degradants in comparison with dabbing | |
| Which ones of them are known to cross the placental barrier, and at what proportion compared to their respective concentrations in the mother’s blood? | No study identified | |||
| Are these carcinogens associated with (future) risk of cancer in the offspring? | Canchola et al.[75] | Human bronchial epithelial cells (BEAS-2B) | Duroquinone in vitamin E acetate vaping emissions | Generated ROS and induced oxidative stress-associated gene expression, including upregulation of NQO1 and HMOX-1 |
| Chen et al.[76] | p53-deficient female and male mice | 10% (w/w) vitamin E (dl-a-tocopherol acetate) | Fetal skin had increased DNA oxidation in homozygous or heterozygous p53-deficient fetuses and enhanced tumorigenesis in such genotypes | |
| Jiang et al.[77] | Human bronchial epithelial cells (BEAS-2B) | Vape liquid diluents were purchased from commercial sources | The presence of thermally transformed toxic byproducts (such as carbonyls, esters, alkyl alcohols, and quinones) inhibited cell proliferation and enhanced cytotoxicity |
A look back to cancer risk in offspring of women who smoked traditional tobacco cigarette
Prior to directly addressing this question for ENDS and marijuana vaping, it is important to briefly look back to what studies found on the cancer risk in the offspring of women who smoked traditional tobacco cigarettes during pregnancy. Conflicting results emerged from this question over the last four decades, but there are converging findings on specific endpoints. First, DNA methylation has been demonstrated in this population of offspring[78-80], involving pathways including those leading to cancer development. Second, studies including meta-analysis[81] revealed that central nervous system cancers[81], of which retinoblastoma[82], were the ones consistently at an increased risk among children whose mothers smoked during pregnancy. However, one recent large meta-analysis[83] did not find an increased risk of neuroblastoma in this population and recommended a longitudinal study. Third, studies involving pregnant mothers (and fathers in some) showed no or unclear association. Leukemia[81,84-87] and lymphoma[81,88] have shown conflicting findings within and between studies, while an increased risk of testicular cancer, although much researched, was not demonstrated over time[89]. This non-exhaustive list of studies indicates that, like tobacco smoking and despite the two types of smoking not exposing the fetus to the same types of carcinogens, our attention should be directed to the developing fetus when considering the possible cancer risk from maternal nicotine and marijuana vaping during pregnancy. As this is a developing topic, the target organs for cancer risk in the offspring may not be specified before the risk itself and its endpoints are well established.
ENDS-contained carcinogens, their transmission from mother to fetus, at what proportion compared to their respective concentrations in the mother’s biological samples, and the associated altered fetal immune response
Harmful carcinogens and their transmission
A wide range of compounds are formed at different temperatures during ENDS use[75]. Hence, multiple chemicals and pathways may interact, leading to adverse health effects, since individual user settings may differ and the number of chemicals and/or byproducts is infinite. Before we examine some of the identified carcinogens in ENDS aerosols, it is important to understand the role played by actively and/or passively inhaling ENDS aerosols. Compounds identified in the heated ENDS aerosol exposure to e-cig aerosols lead to measurable oxidative and inflammatory responses in lung cells and tissues, which, in turn, may result in not fully studied health consequences including pathways to cancer initiation[53]. In terms of carcinogenic chemicals that pregnant ENDS users (and their developing offspring) may be exposed to, aldehydes, metals, tobacco-specific nitrosamines, tobacco alkaloids, polycyclic aromatic hydrocarbons, and volatile organic compounds may be familiar culprits[90]. It is known that hydrocarbons and reactive aldehydes are formed when the liquids in ENDS are heated to high temperatures around 500 °F[91]. Some of these compounds (some of which have been found in counterfeit e-cigarette cartridges such as isoprene, acetaldehyde, ethylbenzene, toluene, acrolein, 1,3-butadiene, and benzene) have been listed by the FDA as harmful or potentially harmful constituents in tobacco products and tobacco smoke[92].
To date, there are no population-level studies on ENDS use and relevant biological concentrations of markers of exposure. In Figure 2, we depict data from the only human study with data on ENDS-associated chemicals and their concentrations in the active user (father), passive subject (mother), and developing fetus. While other time points are available, we only included data collected at 40 weeks of pregnancy for this review. Apart from glycerol, all identified chemicals (mostly metals, i.e., Al, Cr, Ni, Cu, Zn, Sn, and Pb) had much lower concentrations in the cord blood compared to the biological samples collected from the mother or father. The presence of high levels of glycerol in the cord blood compared to other biological matrices in the adults could be due to the contribution from other sources or an accumulation of the product from the passive vape exposures. Identification of glycerol is not uncommon, even when other harmful and potentially harmful constituents, as classified by the FDA, may be undetected[93]. Glycerol is an important component of e-liquid formulations. However, when aerosolized during vaping and one happens to be exposed, such exposures may not be trivial because there may be a resulting disruption to immune homeostasis[94]. In terms of the metals measured in this study, the actual e-cigarette device may be a potential source and metals consistently found in cartridges include cadmium, nickel, lead, chromium, and arsenic[30,90].
Figure 2. Which chemicals can enter maternal-fetal circulation after ENDS exposure? Select data from the only available human study on passive ENDS exposure in a household by Ballbè et al.[57]. ENDS: Electronic nicotine delivery systems.
A recent study revealed an important distinction between ENDS users[45]. One group inhaled aerosol into their lungs and absorbed most of the chemicals (lung inhalers), while the other group exhaled partially depleted chemicals (mouth inhalers). Pregnant lung inhalers may have a higher potential to increase passive ENDS exposures for a developing fetus since more of the aerosols will deposit into the airways and then potentially to circulation and ultimately to the placenta. Research in this area is essential as it can characterize (1) different chemicals that reach the bloodstream for the two groups (lung/mouth inhalers); (2) which chemicals do reach the fetus; and (3) the downstream signaling molecules from local adverse effects of such chemicals. Tables 3 and 4 show a quantitative comparison between the metal constituents in size-segregated ENDS aerosol, their respective estimated lung-deposited doses, and the health risks of these substances from a collection of popular disposal ENDS products[30]. Despite pulmonary deposit being the only studied, this study offers a cancer risk assessment of two target systems: respiratory and central nervous systems. Studies including other systems would add more information to this attempt to quantitatively assess cancer risk after in utero exposure to ENDS, and thus identify potential individual cancers specific to the studied systems and sites.
Estimated lung-deposited doses and cancer and noncancer risks of ENDS aerosol generated from disposable e-cigarettes, by Air Bar - Watermelon Ice[30]
| Chemical | Estimated dose | Cancer risk assessment | Target system | HI | ||
| LADD (g/kg/Day) | ADD (g/kg/Day) | CSF (g/kg/Day)-1 | Cancer risk | |||
| Chromium | 1.96 × 10-3 | 4.58 × 10-3 | a5.1 × 10-1 | 1.0 × 10-3 | Respiratory | 1.14 (Respiratory) |
| Nickel | 1.68 × 10-3 | 3.91 × 10-3 | a9.1 × 10-4 | 1.5 × 10-6 | Respiratory | |
| Manganese | 4.60 × 10-4 | 1.07 × 10-3 | - | CNS | 0.11 (CNS) | |
| Lead | 5.70 × 10-4 | 1.32 × 10-3 | a4.2 × 10-5 | 2.4 × 10-8 | CNS | |
| Aluminum | 1.02 × 10-2 | 2.38 × 10-2 | b- | - | - | |
| Zinc | 1.07 × 10-2 | 2.50 × 10-2 | b- | - | - | |
Estimated lung-deposited doses and cancer risks of ENDS aerosol generated from disposable e-cigarettes, by Puff Bar - Grape[30]
| Chemical | Estimated dose | Cancer Risk assessment | Target system | HI | ||
| LADD (g/kg/Day) | ADD (g/kg/Day) | CSF (g/kg/Day)-1 | Cancer risk | |||
| Chromium | 7.60 × 10-4 | 1.78 × 10-3 | a5.1 × 10-1 | 3.9 × 10-4 | Respiratory | 0.57 (Respiratory) |
| Nickel | 8.70 × 10-4 | 2.04 × 10-3 | a9.1 × 10-4 | 8.0 × 10-7 | Respiratory | |
| Manganese | 2.20 × 10-4 | 5.10 × 10-4 | - | - | CNS | < 0.05 (CNS) |
| Lead | 9.00 × 10-5 | 2.10 × 10-4 | a4.2 × 10-5 | 3.8 × 10-9 | CNS | |
| Aluminum | 3.87 × 10-3 | 9.03 × 10-3 | b- | - | - | - |
| Zinc | 6.13 × 10-3 | 1.43 × 10-2 | b- | - | - | - |
Altered immune response in fetus
While traditional cigarette smoking is much examined for an increased risk for childhood cancer[84,86,87], in the offspring of fathers who smoke at the time of conception and/or during pregnancy, nothing is known about the impact of ENDS use. With the novel chemical mix, ENDS use during pregnancy can induce developmental toxicity such as embryonic oxidative stress, which can have lifelong adverse health effects[95]. Following maternal exposure to ENDS products, adult offspring of mice have been reported to have increased neuroinflammation[62]. For instance, there were increased IL-6 levels in the brain, and elevated
DNA damage
ENDS aerosols can cause DNA damage in multiple organs including lungs, hearts and bladders and these effects may occur through direct or indirect action. The ENDS-associated compound could act as a genotoxic agent or can work in association with a compromised immune system. To highlight the latter point, we focus on hydroquinone (HQ), which has been identified as an ENDS-associated chemical. HQ is a group 3 carcinogen since there is inadequate evidence in humans and limited evidence in experimental animals. Yang et al. reported that HQ mediates benzene-induced hematopoietic toxicity and can lead to disorders such as aplastic anemia and leukemia[96]. It has been suggested that HQ’s carcinogenic action may be through the exacerbation of a natural disease process[97], since it causes genotoxicity in the bone-marrow cells of animal models. Hence, the presence of HQ and/or its metabolites in the uterine environment can work additively or synergistically with other chemicals and influence an offspring’s future health trajectory[98]. It is important to stress that thorough research is needed before flavorings, vitamins, and other additives deemed safe for ingestion are also to be assumed as safe for vaping. For a detailed discussion on how ENDS aerosols can induce mitochondrial toxicity, and DNA fragmentation akin to the pathological pathways triggered by tobacco smoke, see the recent review by Vivarelli et al.[99].
Epigenetics
There was also dysregulation of 24 genes in the lungs of the offspring related to Wnt signaling, 9 genes related to epigenetics, and 7 genes related to inflammation. At 11 weeks of age, JUUL- and house dust mite (HDM)-exposed offspring exhibited pulmonary inflammation compared to their respective air + HDM controls. Additionally, JUUL + HDM female offspring showed decreased methylation of the promoter region of the Il10ra gene[59]. Inhalation of JUUL aerosols during pregnancy may affect the intrauterine environment, impair lung development, and heighten the effects of a cascade of adverse health later in life. Additionally, there is the possibility of epigenetic programming that can influence future lung disease in offspring[58]. These cascades of events in the future may be due to ENDS-associated byproducts that create a proinflammatory environment within which the fetus develops[60].
Gene expression changes
One clear lesson from traditional tobacco use can be gleaned from genotype studies. A single nucleotide polymorphism of the α5 nicotinic receptor [where residue 398 changes aspartic acid, Asp (D), to asparagine, Asn (N) (rs16969968)] is associated with maternal smoking and has detrimental effects on the offspring’s pulmonary function[100]. This SNP, combined with smoking, increases the risk of lung cancer and chronic obstructive pulmonary disease[101]. Conversely, pregnant e-cig users with this genotype may increase the risk of such adverse health outcomes in their offspring. Individuals who had in utero exposure to e-cig aerosols could be predisposed to developing chronic disease later in life, since e-cig aerosols can lead to dysregulated extracellular matrix remodeling, which is in turn associated with pathological conditions such as fibrosis and cancer[102-104]. In sum, excessive production of reactive oxygen and nitrogen species by phagocytes can initiate cancer development [105]. On the other hand, in utero exposure to e-cigarette aerosols can lead to altered fetal lung gene expression, and this may contribute to future disease development. For instance, Orzabal et al. noted that the top 10 downregulated and upregulated genes of offspring exposed to prenatal
Before proceeding to the next section of our discussion, it would be remiss to overlook potential methodological changes in several of the studies presented herein. First, there is the issue of aerosol generation that is relevant to humans. A recent review has identified differences between laboratory tests of vape emissions to provide evidence of potential health risks from exposure and actual human experiences[107]. For instance, Yan et al. performed their experiment at a high power of up to 200 W, with a low airflow of 1 L/min[56]. This may have resulted in overheating conditions, which, in turn, led to increased production of aldehydes, but this is not comparable to human vape users. Likewise, in a study by Cahill et al., mice were subjected to whole-body exposure, with aerosols generated through an airflow pump set at
Marijuana vape-contained carcinogens, their transmission from mother to fetus, and the associated altered fetal immune response
Like for ENDS, we also need to understand the impact of actively and/or passively inhaling marijuana vape aerosols. Tang et al. highlight the important role of ultrafine particles[31]. Such particles act as carriers of low-molecular-weight species and can influence exposure in two ways. First, the chemically bound particles can help transport these chemicals deep into the user’s respiratory system and ultimately into the circulatory system. Secondly, nonusers can be exposed when these chemically bound particles disperse nonvolatile and semi-volatile species in the indoor environment. Whether through this first or second route, the researchers collected air samples and noted that such samples had about 50% of emitted monoterpenes and less than 40% of released sesquiterpenes and terpene alcohols. Furthermore, a large proportion of ultrafine particles were released when the mixture was heated and remained airborne for at least 3 h, and thus, active and passive marijuana vape users can still be exposed to the associated compounds even after ceasing active use. Certainly, further research on the impacts of these emerging vape products is needed to understand their effects on users and nonusers alike.
Harmful carcinogens and their transmission
Wu and O’Shea found that the pyrolysis of vitamin E acetate led to the production of carcinogenic alkenes and benzene[108]. The authors state that at high temperatures, there is a huge potential for unexpected chemistries to occur among the individual components of a vape mixture. Using a combination of analytical, theoretical, and experimental approaches, Wu and O’Shea identified compounds such as vitamin E acetate, ketene, 2,3,5,6-tetramethylcyclohexa-2,5-diene-1,4-dione, (duroquinone) and prist-1-ene, butadiene, propene, ethene, 2-methylprop-1-ene, and 1-methyl-1-alkyl-alkenes, as well as trace amounts of tetrahydrofuran, formaldehyde, and short-chain aliphatic aldehydes. Ketene (ethenone) has also been reported in vaped condensates from cannabinoid acetates and commercial Δ8-THC acetate products[109]. A handful of studies have shown disturbing and detrimental effects of acute ketene toxicity, including inflammation[110]; however, long-term consequences of exposure to this compound, by itself or in a mixture with other toxic chemicals, remain unknown. Finally, like in ENDS, metals have also been found in marijuana vaping devices, i.e., nickel, chromium, copper, lead, tin, and gold[111]. Like for other metals in ENDS cartridges, nickel and chromium components have been detected in the devices used by patients who were diagnosed with EVALI[111], while other devices contained copper, lead, tin, and gold, which all have the potential to thermally degrade and volatilize when heated. Moving forward, for both ENDS and marijuana vaping devices, healthcare centers, state and federal programs such as the National Health and Nutrition Examination Survey (NHANES)[112] or the Alberta Biomonitoring Program[113] can employ similar strategies to provide effective models for population biomonitoring. Of the metals found in marijuana vaping devices (nickel, chromium, copper, lead, tin, gold)[111], all but gold crossed the placenta barrier in an ENDS study on humans[57]. However, we found no study that specifically addressed transmission of carcinogens found in marijuana-vaping devices from pregnant mother to the developing fetus.
Altered immune response
Cannabidiol has been shown to induce excessive production of reactive oxygen[114], which, as we said earlier, can initiate cancer development[105]. It is therefore important to understand the major constituents in marijuana vape and their amounts in vapor or aerosols that get into a user’s lungs by comparing the major constituents in unused vape oil vs. its vaporized and aerosolized forms. While terpenes and minor cannabinoids can be produced when vaporizing and aerosolizing the vape oil, some of these have been found at lower levels in the vapor and aerosol than in the vape liquid[41] and some unlabeled chemicals have been detected[54,105]. In utero exposure to cannabinoids is associated with T cell dysfunction, an impaired immune response to viruses and susceptibility to cancer[115]. In one of the first studies to investigate the gas-phase thermal degradants of Δ9-THC, Meehan-Atrash et al. evaluated the safety of THC degradants[74]. While this has not been shown in humans, cancer studies in experimental animals showed that these individual chemicals have led to cancer upon exposure. For instance, isoprene caused blood-vessel cancer and benign or malignant tumors of the Harderian gland (adenoma or carcinoma) and the lung (alveolar/bronchiolar adenoma or carcinoma) across both male and female mice. Additionally, in both male and female rats, isoprene caused benign or malignant tumors of the mammary gland (fibroadenoma or carcinoma) and kidney (renal-cell adenoma or carcinoma). Benign tumors of the testis (adenoma) have also been reported in male rats.
DNA damage and epigenetic changes
There is also the potential for parental cannabis use to trigger epigenetic modifications (such as altered microRNA, DNA methylation, and histone modification profiles) with long-term transgenerational effects[115]. Furthermore, cannabis inhalation is novel and differs from cannabis smoking and there is little current data to correctly assess their safety[116]; therefore, further research is needed to assess and characterize this constantly evolving field of commercial vaporizers.
Limitations
This review has several limitations. First, we limited our search to PubMed, which may have caused us to miss potentially relevant studies retrievable in other databases, including the grey literature[117,118]. However, PubMed has the strength of capturing a wide range of studies and a good refinement algorithm, when MeSH term options are used in the search[119]. Second, our search was restricted to studies published in English, which may not have accounted for studies published in other languages. Third, not all ENDS and marijuana aerosol/vapor papers were considered for analysis, but only those that pointed to developmental effects or suggested developmental or immune consequences. Even within the aspect of the effects on development, we focused on those addressing cancer development pathways during development - implying long-term effects. Therefore, studies that addressed the short-term effects, such as those of marijuana vaping use during pregnancy on the fetus birthweight or neurodevelopment outcomes, are not discussed. Additionally, we acknowledge but do not discuss other sources and potential for transfer of organic contaminants (or their metabolites) to the developing fetus, as this is beyond the scope of the current work. Finally, our search period ended in December 2022. Given the ongoing influx of new studies on this topic, our findings may not capture the most inclusive update on the topic. However, when considering the 20-year scope of our search, extending it into 2023 at the time of the writing of this review would not have added a high volume of relevant studies to include.
Thoughts for future directions
In sum, in utero exposure to parent or biotransformed ENDS- or marijuana vape-associated chemicals can occur in vital organs such as lungs, kidneys, brain, bladder, and heart. The byproducts can be further metabolized into DNA-damaging agents and increase the risk of tumorigenesis. Such altered intrauterine environment can impair fetal development and heighten the effects of a cascade of future adverse health events, including cancer. However, to date, studies directly assessing related cancer risk after in utero exposure in human fetuses are nonexistent. Recent studies showed that exposure to thirdhand smoke exposures from traditional cigarette use can alter body weight and immunity, and lead to lung cancer development in mice[120]. One key factor is genetic susceptibility to various forms of cancer, as has been demonstrated in different mouse strains[121]. Since some of these chemicals in traditional cigarette smoke have been reported when marijuana and nicotine vape products are used, the adverse health effects of thirdhand smoke from these emerging products need to be thoroughly understood as well. Future epidemiological studies are needed to examine the effects of passive aerosol exposures from existing and emerging electronic nicotine and marijuana products on vulnerable populations including developing fetuses, infants, children, and those with genetic susceptibility to cancer[88].
DECLARATIONS
Acknowledgement
The authors would like to thank the Indiana University science librarian Thea Atwood for providing the team with invaluable technical assistance in search strategy building, to Sajjad Khan and the Silveyra Lab (Rachel Alford, Maksat Babayev, Dr. Carolyn D. Ekpruke, Dustin Rousselle, Shikha Sharma, and Dr. Patricia Silveyra) for early feedback provided at the conceptualization stage, and to Drs Juhua Luo and Douglas Landsittel for mentorship to Ndeke JM.
Authors’ contributions
Conceptualization, study abstracts screening, full-paper review, manuscript writing - original draft, manuscript writing - review and editing, visualization: Ndeke JM, Commodore S
Conceptualization and extensive review and editing: Klaunig JE
PubMed search strategy and queries: Ndeke JM, Commodore S
Availability of data and materials
The complete PubMed search strategy used for this review is provided in the Supplementary Materials.
Financial support and sponsorship
Ndeke JM received funding from a NIH/NCI T32 fellowship. Research reported in this publication was supported by the National Cancer Institute of the National Institutes of Health under Award Number T32CA117865. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.
Conflicts of interest
All authors declared that there are no conflicts of interest.
Ethical approval and consent to participate
Not applicable.
Consent for publication
Not applicable.
Copyright
© The Authors 2024.
Supplementary Materials
REFERENCES
1. Public Health Service, Department of Health, Education, and Welfare. Smoking and health: report of the Advisory Committee to the Surgeon General of the public health service. 1964. Available from: https://www.govinfo.gov/app/details/GPO-SMOKINGANDHEALTH. [Last accessed on 11 Apr 2024].
2. Centers for Disease Control and Prevention (US), National Center for Chronic Disease Prevention and Health Promotion (US), Office on Smoking and Health (US). How tobacco smoke causes disease: the biology and behavioral basis for smoking-attributable disease: a report of the surgeon general. 2010. Available from: https://www.ncbi.nlm.nih.gov/books/NBK53017/. [Last accessed on 11 Apr 2024].
3. Sears CG, Walker KL, Hart JL, Lee AS, Siu A, Smith C. Clean, cheap, convenient: promotion of Electronic cigarettes on YouTube. Tob Prev Cessat 2017;3:10.
4. Lyu JC, Huang P, Jiang N, Ling PM. A systematic review of e-cigarette marketing communication: messages, communication channels, and strategies. Int J Environ Res Public Health 2022;19:9263.
5. de Andrade M, Hastings G, Angus K. Promotion of electronic cigarettes: tobacco marketing reinvented? BMJ 2013;347:f7473.
6. Rodrigo G, Jaccard G, Tafin Djoko D, Korneliou A, Esposito M, Belushkin M. Cancer potencies and margin of exposure used for comparative risk assessment of heated tobacco products and electronic cigarettes aerosols with cigarette smoke. Arch Toxicol 2021;95:283-98.
7. U.S. Food & Drug Administration. FDA permits marketing of e-cigarette products, marking first authorization of its kind by the agency. 2021. Available from: https://www.fda.gov/news-events/press-announcements/fda-permits-marketing-e-cigarette-products-marking-first-authorization-its-kind-agency. [Last accessed on 11 Apr 2024].
8. National Institute for Health and Care Excellence (NICE). Tobacco: preventing uptake, promoting quitting and treating dependence. 2021. Available from: https://www.nice.org.uk/guidance/ng209. [Last accessed on 11 Apr 2024].
9. Ministry of Health of New Zealand. Our position on vaping. 2022. Available from: https://vapingfacts.health.nz/our-position-on-vaping.html. [Last accessed on 11 Apr 2024].
10. Miech R, Johnston L, O’Malley PM, Bachman JG, Patrick ME. Adolescent vaping and nicotine use in 2017-2018 - U.S. National Estimates. N Engl J Med 2019;380:192-3.
11. White J, Li J, Newcombe R, Walton D. Tripling use of electronic cigarettes among New Zealand adolescents between 2012 and 2014. J Adolesc Health 2015;56:522-8.
12. Soneji S, Barrington-Trimis JL, Wills TA, et al. Association between initial use of e-cigarettes and subsequent cigarette smoking among adolescents and young adults: a systematic review and meta-analysis. JAMA Pediatr 2017;171:788-97.
13. D’Angelo H, Patel M, Rose SW. Convenience store access and e-cigarette advertising exposure is associated with future e-cigarette initiation among tobacco-naïve youth in the PATH study (2013-2016). J Adolesc Health 2021;68:794-800.
14. Pokhrel P, Fagan P, Herzog TA, et al. E-cigarette advertising exposure and implicit attitudes among young adult non-smokers. Drug Alcohol Depend 2016;163:134-40.
15. Bhandari NR, Day KD, Payakachat N, Franks AM, McCain KR, Ragland D. Use and risk perception of electronic nicotine delivery systems and tobacco in pregnancy. Womens Health Issues 2018;28:251-7.
17. England LJ, Tong VT, Koblitz A, Kish-Doto J, Lynch MM, Southwell BG. Perceptions of emerging tobacco products and nicotine replacement therapy among pregnant women and women planning a pregnancy. Prev Med Rep 2016;4:481-5.
18. Grigsby TM, Hoffmann LM, Moss MJ. Marijuana use and potential implications of marijuana legalization. Pediatr Rev 2020;41:61-72.
19. 10 Cancers. In: National Academies of Sciences, Engineering, and Medicine; Health and Medicine Division; Board on Population Health and Public Health Practice; Committee on the Review of the Health Effects of Electronic Nicotine Delivery Systems. Eaton DL, Kwan LY, Stratton K, editors. Public health consequences of e-cigarettes. Washington (DC): National Academies Press (US). 2018. Available from: https://www.ncbi.nlm.nih.gov/books/NBK507174/. [Last accessed on 11 Apr 2024].
20. WHO Framework Convention on Tobacco Control. Electronic nicotine delivery systems: Report by WHO. 2014. Available from: https://apps.who.int/gb/fctc/PDF/cop6/FCTC_COP6_10Rev1-en.pdf. [Last accessed on 11 Apr 2024].
21. Kapaya M, D’Angelo DV, Tong VT, et al. Use of electronic vapor products before, during, and after pregnancy among women with a recent live birth - Oklahoma and Texas, 2015. MMWR 2019;68:189-94. Available from: https://www.cdc.gov/mmwr/volumes/68/wr/mm6808a1.htm. [Last accessed on 11 Apr 2024]
22. Price LR, Martinez J. Cardiovascular, carcinogenic and reproductive effects of nicotine exposure: a narrative review of the scientific literature. F1000Res 2019;8:1586.
23. Benowitz NL, Burbank AD. Cardiovascular toxicity of nicotine: implications for electronic cigarette use. Trends Cardiovasc Med 2016;26:515-23.
24. Benowitz NL, Fraiman JB. Cardiovascular effects of electronic cigarettes. Nat Rev Cardiol 2017;14:447-56.
25. Goniewicz ML, Miller CR, Sutanto E, Li D. How effective are electronic cigarettes for reducing respiratory and cardiovascular risk in smokers? A systematic review. Harm Reduct J 2020;17:91.
26. Skotsimara G, Antonopoulos AS, Oikonomou E, et al. Cardiovascular effects of electronic cigarettes: a systematic review and meta-analysis. Eur J Prev Cardiol 2019;26:1219-28.
27. Znyk M, Jurewicz J, Kaleta D. Exposure to heated tobacco products and adverse health effects, a systematic review. Int J Environ Res Public Health 2021;18:6651.
28. Sanner T, Grimsrud TK. Nicotine: carcinogenicity and effects on response to cancer treatment - a review. Front Oncol 2015;5:196.
29. Tarran R, Barr RG, Benowitz NL, et al. E-cigarettes and cardiopulmonary health. Function 2021;2:zqab004.
30. Lin HC, Buu A, Su WC. Disposable e-cigarettes and associated health risks: an experimental study. Int J Environ Res Public Health 2022;19:10633.
31. Tang X, Cancelada L, Rapp VH, et al. Emissions from heated terpenoids present in vaporizable cannabis concentrates. Environ Sci Technol 2021;55:6160-70.
32. Farsalinos KE, Voudris V, Spyrou A, Poulas K. E-cigarettes emit very high formaldehyde levels only in conditions that are aversive to users: a replication study under verified realistic use conditions. Food Chem Toxicol 2017;109:90-4.
33. Ruggiero JL, Voller LM, Shaik JA, Hylwa S. Formaldehyde in electronic cigarette liquid (aerosolized liquid). Dermatitis 2022;33:332-6.
34. Huang SJ, Xu YM, Lau ATY. Electronic cigarette: a recent update of its toxic effects on humans. J Cell Physiol 2018;233:4466-78.
35. National Academies of Sciences, Engineering, and Medicine; Health and Medicine Division; Board on Population Health and Public Health Practice; Committee on the Health Effects of Marijuana: An Evidence Review and Research Agenda. The health effects of cannabis and cannabinoids: the current state of evidence and recommendations for research. Washington (DC): The National Academies Press. 2017. Available from: https://www.ncbi.nlm.nih.gov/books/NBK423845/. [Last accessed on 11 Apr 2024].
36. Hickman E, Payton A, Duffney P, et al. Biomarkers of airway immune homeostasis differ significantly with generation of e-cigarettes. Am J Respir Crit Care Med 2022;206:1248-58.
38. Dugué PA, Rebolj M, Garred P, Lynge E. Immunosuppression and risk of cervical cancer. Expert Rev Anticancer Ther 2013;13:29-42.
40. Mortaz E, Tabarsi P, Mansouri D, et al. Cancers related to immunodeficiencies: update and perspectives. Front Immunol 2016;7:365.
41. Guo W, Vrdoljak G, Liao VC, Moezzi B. Major constituents of cannabis vape oil liquid, vapor and aerosol in california vape oil cartridge samples. Front Chem 2021;9:694905.
42. Su WC, Lee J, Zhang K, Wong SW, Buu A. Estimation of health risks caused by metals contained in e-cigarette aerosol through passive vaping. Toxics 2023;11:684.
43. Li Y, Dai J, Tran LN, Pinkerton KE, Spindel ER, Nguyen TB. Vaping aerosols from vitamin e acetate and tetrahydrocannabinol oil: chemistry and composition. Chem Res Toxicol 2022;35:1095-109.
44. Peacock JL, Palys TJ, Halchenko Y, et al. Assessing tobacco smoke exposure in pregnancy from self-report, urinary cotinine and NNAL: a validation study using the New Hampshire Birth Cohort Study. BMJ Open 2022;12:e054535.
45. Kheirkhah Rahimabad P, Anthony TM, Jones AD, et al. Nicotine and its downstream metabolites in maternal and cord sera: biomarkers of prenatal smoking exposure associated with offspring DNA methylation. Int J Environ Res Public Health 2020;17:9552.
46. Kawasaki Y, Li YS, Ootsuyama Y, et al. Assessment of exposure and DNA damage from second-hand smoke using potential biomarker in urine: cigarettes and heated tobacco products. J Clin Biochem Nutr 2023;72:242-7.
47. IARC Working Group on the Evaluation of Carcinogenic Risks to Humans. Smokeless tobacco and some tobacco-specific N-nitrosamines. IARC Monogr Eval Carcinog Risks Hum 2007;89:1-592. Available from: https://www.ncbi.nlm.nih.gov/books/NBK326497/. [Last accessed on 11 Apr 2024]
49. Pizzino G, Irrera N, Cucinotta M, et al. Oxidative stress: harms and benefits for human health. Oxid Med Cell Longev 2017;2017:8416763.
51. Davis JM, Welty SE. Maturation of the fetal antioxidant system and the unique susceptibility of the newborn infant to oxidative stress. In: I Laher, Editor. Systems biology of free radicals and antioxidants. Springer Berlin Heidelberg: Berlin, Heidelberg. 2014. pp. 597-616.
52. Chen CS, Squire JA, Wells PG. Reduced tumorigenesis in p53 knockout mice exposed in utero to low-dose vitamin E. Cancer 2009;115:1563-75.
53. Lerner CA, Sundar IK, Yao H, et al. Vapors produced by electronic cigarettes and e-juices with flavorings induce toxicity, oxidative stress, and inflammatory response in lung epithelial cells and in mouse lung. PLoS One 2015;10:e0116732.
54. Holt AK, Poklis JL, Peace MR. A retrospective analysis of chemical constituents in regulated and unregulated e-cigarette liquids. Front Chem 2021;9:752342.
55. Lim HH, Shin HS. Determination of volatile organic compounds including alcohols in refill fluids and cartridges of electronic cigarettes by headspace solid-phase micro extraction and gas chromatography-mass spectrometry. Anal Bioanal Chem 2017;409:1247-56.
56. Yan B, Zagorevski D, Ilievski V, et al. Identification of newly formed toxic chemicals in e-cigarette aerosols with Orbitrap mass spectrometry and implications on e-cigarette control. Eur J Mass Spectrom 2021;27:141-8.
57. Ballbè M, Fu M, Masana G, et al. Passive exposure to electronic cigarette aerosol in pregnancy: a case study of a family. Environ Res 2023;216:114490.
58. Cahill KM, Gartia MR, Sahu S, et al. In utero exposure to electronic-cigarette aerosols decreases lung fibrillar collagen content, increases Newtonian resistance and induces sex-specific molecular signatures in neonatal mice. Toxicol Res 2022;38:205-24.
59. Cahill KM, Johnson TK, Perveen Z, et al. In utero exposures to mint-flavored JUUL aerosol impair lung development and aggravate house dust mite-induced asthma in adult offspring mice. Toxicology 2022;477:153272.
60. Chen H, Li G, Chan YL, et al. Maternal e-cigarette exposure in mice alters DNA methylation and lung cytokine expression in offspring. Am J Respir Cell Mol Biol 2018;58:366-77.
61. Chua TH, Takano A, Yao YJ, Chow SY, Devanand A, Tay CK. Autoimmune pulmonary alveolar proteinosis with a history of vaping and vitamin e-positive bronchoalveolar lavage. Respirol Case Rep 2021;9:e0864.
62. Church JS, Chace-Donahue F, Blum JL, Ratner JR, Zelikoff JT, Schwartzer JJ. Neuroinflammatory and behavioral outcomes measured in adult offspring of mice exposed prenatally to e-cigarette aerosols. Environ Health Perspect 2020;128:47006.
63. Lee HW, Park SH, Weng MW, et al. E-cigarette smoke damages DNA and reduces repair activity in mouse lung, heart, and bladder as well as in human lung and bladder cells. Proc Natl Acad Sci U S A 2018;115:E1560-9.
64. Hickman E, Herrera CA, Jaspers I. Common e-cigarette flavoring chemicals impair neutrophil phagocytosis and oxidative burst. Chem Res Toxicol 2019;32:982-5.
65. Landmesser A, Scherer M, Scherer G, et al. Assessment of the potential vaping-related exposure to carbonyls and epoxides using stable isotope-labeled precursors in the e-liquid. Arch Toxicol 2021;95:2667-76.
66. Li G, Chan YL, Nguyen LT, et al. Impact of maternal e-cigarette vapor exposure on renal health in the offspring. Ann N Y Acad Sci 2019;1452:65-77.
67. Li G, Chan YL, Wang B, et al. E-cigarettes damage the liver and alter nutrient metabolism in pregnant mice and their offspring. Ann N Y Acad Sci 2020;1475:64-77.
68. Noël A, Hansen S, Zaman A, et al. In utero exposures to electronic-cigarette aerosols impair the Wnt signaling during mouse lung development. Am J Physiol Lung Cell Mol Physiol 2020;318:L705-22.
69. Orzabal MR, Naik VD, Lee J, et al. Impact of e-cig aerosol vaping on fetal and neonatal respiratory development and function. Transl Res 2022;246:102-14.
70. Rickard BP, Ho H, Tiley JB, Jaspers I, Brouwer KLR. E-cigarette flavoring chemicals induce cytotoxicity in HepG2 cells. ACS Omega 2021;6:6708-13.
71. Wang Q, Sundar IK, Blum JL, et al. Prenatal exposure to electronic-cigarette aerosols leads to sex-dependent pulmonary extracellular-matrix remodeling and myogenesis in offspring mice. Am J Respir Cell Mol Biol 2020;63:794-805.
72. Canchola A, Meletz R, Khandakar RA, Woods M, Lin YH. Temperature dependence of emission product distribution from vaping of vitamin E acetate. PLoS One 2022;17:e0265365.
73. LeBouf RF, Ranpara A, Ham J, et al. Chemical emissions from heated vitamin E acetate-insights to respiratory risks from electronic cigarette liquid oil diluents used in the aerosolization of Δ9-THC-containing products. Front Public Health 2021;9:765168.
74. Meehan-Atrash J, Luo W, McWhirter KJ, Strongin RM. Aerosol gas-phase components from cannabis e-cigarettes and dabbing: mechanistic insight and quantitative risk analysis. ACS Omega 2019;4:16111-20.
75. Canchola A, Ahmed CMS, Chen K, Chen JY, Lin YH. Formation of redox-active duroquinone from vaping of vitamin E acetate contributes to oxidative lung injury. Chem Res Toxicol 2022;35:254-64.
76. Chen CS, Wells PG. Enhanced tumorigenesis in p53 knockout mice exposed in utero to high-dose vitamin E. Carcinogenesis 2006;27:1358-68.
77. Jiang H, Ahmed CMS, Martin TJ, et al. Chemical and toxicological characterization of vaping emission products from commonly used vape juice diluents. Chem Res Toxicol 2020;33:2157-63.
78. Joubert BR, Felix JF, Yousefi P, et al. DNA methylation in newborns and maternal smoking in pregnancy: genome-wide consortium meta-analysis. Am J Hum Genet 2016;98:680-96.
79. Terry MB, Delgado-Cruzata L, Vin-Raviv N, Wu HC, Santella RM. DNA methylation in white blood cells: association with risk factors in epidemiologic studies. Epigenetics 2011;6:828-37.
80. Tehranifar P, Wu HC, McDonald JA, et al. Maternal cigarette smoking during pregnancy and offspring DNA methylation in midlife. Epigenetics 2018;13:129-34.
81. Rumrich IK, Viluksela M, Vähäkangas K, Gissler M, Surcel HM, Hänninen O. Maternal smoking and the risk of cancer in early life - a meta-analysis. PLoS One 2016;11:e0165040.
82. He D, Huang X, Uppal K, et al. Biomarkers of maternal smoking and the risk of retinoblastoma in offspring. Retina 2023;43:481-9.
83. Karalexi MA, Katsimpris A, Panagopoulou P, et al. NARECHEM-ST collaborating group. Maternal lifestyle factors and risk of neuroblastoma in the offspring: a meta-analysis including Greek NARECHEM-ST primary data. Cancer Epidemiol 2022;77:102055.
84. Frederiksen LE, Erdmann F, Wesseling C, Winther JF, Mora AM. Parental tobacco smoking and risk of childhood leukemia in Costa Rica: a population-based case-control study. Environ Res 2020;180:108827.
85. Ferreira JD, Couto AC, Pombo-de-Oliveira MS, Koifman S. Brazilian Collaborative Study Group of Infant Acute Leukemia. Pregnancy, maternal tobacco smoking, and early age leukemia in Brazil. Front Oncol 2012;2:151.
86. Milne E, Greenop KR, Scott RJ, et al. Parental prenatal smoking and risk of childhood acute lymphoblastic leukemia. Am J Epidemiol 2012;175:43-53.
87. Metayer C, Zhang L, Wiemels JL, et al. Tobacco smoke exposure and the risk of childhood acute lymphoblastic and myeloid leukemias by cytogenetic subtype. Cancer Epidemiol Biomarkers Prev 2013;22:1600-11.
88. Snijders AM, Zhou M, Whitehead TP, et al. In utero and early-life exposure to thirdhand smoke causes profound changes to the immune system. Clin Sci 2021;135:1053-63.
89. Beck AL, Uldbjerg CS, Lim YH, et al. Cotinine concentrations in maternal serum and amniotic fluid during pregnancy and risk of testicular germ cell cancer in the offspring: a prospective nested case-control study. Int J Cancer 2024;154:71-80.
91. Muthumalage T, Friedman MR, McGraw MD, Ginsberg G, Friedman AE, Rahman I. Chemical constituents involved in e-cigarette, or vaping product use-associated lung injury (EVALI). Toxics 2020;8:25.
92. The Unites States Food and Drug Administration (FDA). Harmful and potentially harmful constituents in tobacco products and tobacco smoke: established list. 2012. Available from: https://www.fda.gov/tobacco-products/rules-regulations-and-guidance/harmful-and-potentially-harmful-constituents-tobacco-products-and-tobacco-smoke-established-list. [Last accessed on 11 Apr 2024].
93. Pinto MI, Thissen J, Hermes N, Cunningham A, Digard H, Murphy J. Chemical characterisation of the vapour emitted by an e-cigarette using a ceramic wick-based technology. Sci Rep 2022;12:16497.
94. Szafran BN, Pinkston R, Perveen Z, et al. Electronic-cigarette vehicles and flavoring affect lung function and immune responses in a murine model. Int J Mol Sci 2020;21:6022.
95. Maciag MC, Yousuf A, Hauptman M. Impact of prenatal exposure to smoking on child health. Clin Obstet Gynecol 2022;65:388-96.
96. Yang X, Li C, Yu G, et al. Ligand-independent activation of AhR by hydroquinone mediates benzene-induced hematopoietic toxicity. Chem Biol Interact 2022;355:109845.
97. McGregor D. Hydroquinone: an evaluation of the human risks from its carcinogenic and mutagenic properties. Crit Rev Toxicol 2007;37:887-914.
98. Heluany CS, De Palma A, Day NJ, Farsky SHP, Nalesso G. Hydroquinone, an environmental pollutant, affects cartilage homeostasis through the activation of the aryl hydrocarbon receptor pathway. Cells 2023;12:690.
99. Vivarelli F, Granata S, Rullo L, et al. On the toxicity of e-cigarettes consumption: focus on pathological cellular mechanisms. Pharmacol Res 2022;182:106315.
100. McEvoy CT, Schilling D, Clay N, et al. Vitamin C supplementation for pregnant smoking women and pulmonary function in their newborn infants: a randomized clinical trial. JAMA 2014;311:2074-82.
101. Spindel ER, McEvoy CT. The role of nicotine in the effects of maternal smoking during pregnancy on lung development and childhood respiratory disease. Implications for dangers of e-cigarettes. Am J Respir Crit Care Med 2016;193:486-94.
102. Berg J, Halvorsen AR, Bengtson MB, et al. Levels and prognostic impact of circulating markers of inflammation, endothelial activation and extracellular matrix remodelling in patients with lung cancer and chronic obstructive pulmonary disease. BMC Cancer 2018;18:739.
103. Bonnans C, Chou J, Werb Z. Remodelling the extracellular matrix in development and disease. Nat Rev Mol Cell Biol 2014;15:786-801.
104. Girigoswami K, Saini D, Girigoswami A. Extracellular matrix remodeling and development of cancer. Stem Cell Rev Rep 2021;17:739-47.
105. Tavares-da-Silva EJ, Varela CL, Pires AS, et al. Combined dual effect of modulation of human neutrophils’ oxidative burst and inhibition of colon cancer cells proliferation by hydroxycinnamic acid derivatives. Bioorg Med Chem 2016;24:3556-64.
106. Kelly-Robinson GA, Reihill JA, Lundy FT, et al. The serpin superfamily and their role in the regulation and dysfunction of serine protease activity in COPD and other chronic lung diseases. Int J Mol Sci 2021;22:6351.
107. Soulet S, Sussman RA. Critical review of the recent literature on organic byproducts in e-cigarette aerosol emissions. Toxics 2022;10:714.
108. Wu D, O’Shea DF. Potential for release of pulmonary toxic ketene from vaping pyrolysis of vitamin E acetate. Proc Natl Acad Sci U S A 2020;117:6349-55.
109. Munger KR, Jensen RP, Strongin RM. Vaping cannabinoid acetates leads to ketene formation. Chem Res Toxicol 2022;35:1202-5.
110. Attfield KR, Chen W, Cummings KJ, et al. Potential of ethenone (Ketene) to contribute to electronic cigarette, or vaping, product use-associated lung injury. Am J Respir Crit Care Med 2020;202:1187-9.
111. Wagner J, Chen W, Vrdoljak G. Vaping cartridge heating element compositions and evidence of high temperatures. PLoS One 2020;15:e0240613.
112. Hirth JM, Valadez C, Gonzalez S, Kowalchuk A, Gutierrez JA, Zoorob R. Racial/ethnic variations in alcohol and cigarette use by pregnancy status among 20- to 44-year-old women, NHANES 2001-2018. Womens Health 2022;18:17455057221112188.
113. MacDonald AM, Gabos S, Braakman S, et al. Maternal and child biomonitoring strategies and levels of exposure in western Canada during the past seventeen years: the Alberta Biomonitoring Program: 2005-2021. Int J Hyg Environ Health 2022;244:113990.
114. Wu HY, Huang CH, Lin YH, Wang CC, Jan TR. Cannabidiol induced apoptosis in human monocytes through mitochondrial permeability transition pore-mediated ROS production. Free Radic Biol Med 2018;124:311-8.
115. Zumbrun EE, Sido JM, Nagarkatti PS, Nagarkatti M. Epigenetic regulation of immunological alterations following prenatal exposure to marijuana cannabinoids and its long term consequences in offspring. J Neuroimmune Pharmacol 2015;10:245-54.
116. Meehan-Atrash J, Rahman I. Cannabis vaping: existing and emerging modalities, chemistry, and pulmonary toxicology. Chem Res Toxicol 2021;34:2169-79.
117. Gusenbauer M. Search where you will find most: comparing the disciplinary coverage of 56 bibliographic databases. Scientometrics 2022;127:2683-745.
118. Bramer WM, Rethlefsen ML, Kleijnen J, Franco OH. Optimal database combinations for literature searches in systematic reviews: a prospective exploratory study. Syst Rev 2017;6:245.
119. Shultz M. Comparing test searches in PubMed and Google Scholar. J Med Libr Assoc 2007;95:442-5.
120. Hang B, Mao JH, Snijders AM. Genetic susceptibility to thirdhand-smoke-induced lung cancer development. Nicotine Tob Res 2019;21:1294-6.
Cite This Article
Export citation file: BibTeX | RIS
OAE Style
Ndeke JM, Klaunig JE, Commodore S. Nicotine or marijuana vaping exposure during pregnancy and altered immune responses in offspring. J Environ Expo Assess 2024;3:11. http://dx.doi.org/10.20517/jeea.2024.03
AMA Style
Ndeke JM, Klaunig JE, Commodore S. Nicotine or marijuana vaping exposure during pregnancy and altered immune responses in offspring. Journal of Environmental Exposure Assessment. 2024; 3(1): 11. http://dx.doi.org/10.20517/jeea.2024.03
Chicago/Turabian Style
Ndeke, Jonas M., James E. Klaunig, Sarah Commodore. 2024. "Nicotine or marijuana vaping exposure during pregnancy and altered immune responses in offspring" Journal of Environmental Exposure Assessment. 3, no.1: 11. http://dx.doi.org/10.20517/jeea.2024.03
ACS Style
Ndeke, JM.; Klaunig JE.; Commodore S. Nicotine or marijuana vaping exposure during pregnancy and altered immune responses in offspring. J. Environ. Expo. Assess. 2024, 3, 11. http://dx.doi.org/10.20517/jeea.2024.03
About This Article
Special Issue
Copyright
Data & Comments
Data
0
Cite This Article 1 clicks
Like This Article 0
likes
Comments
Comments must be written in English. Spam, offensive content, impersonation, and private information will not be permitted. If any comment is reported and identified as inappropriate content by OAE staff, the comment will be removed without notice. If you have any queries or need any help, please contact us at support@oaepublish.com.